615731650	615731650	CD	B-NP	O
|	|	NN	I-NP	O
ATSMC	ATSMC	NN	I-NP	O
|	|	NN	I-NP	O
09399642	09399642	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
2251348	2251348	CD	B-NP	O
|	|	CC	I-NP	O
7/3/2005	7/3/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
APLASTIC	APLASTIC	NNP	I-NP	I-protein
ANEMIA	ANEMIA	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/21/2005	9/21/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/13/2005	7/13/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
COGER	COGER	NN	B-NP	B-protein
,	,	,	O	O
LOU	LOU	NNP	B-NP	O
MD	MD	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	NNP	B-NP	O
ILLNESS	ILLNESS	NNP	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
41-year-old	41-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
aplastic	aplastic	JJ	B-NP	O
anemia	anemia	NN	I-NP	O
since	since	IN	B-PP	O
age	age	NN	B-NP	O
12	12	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
transfusion	transfusion	NN	I-NP	O
dependent	dependent	JJ	B-ADJP	O
,	,	,	O	O
usually	usually	RB	B-ADVP	O
every	every	DT	B-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
iron	iron	NN	B-NP	O
overload	overload	NN	I-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
avascular	avascular	JJ	B-NP	O
necrosis	necrosis	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
hip	hip	NN	I-NP	O
replacement	replacement	NN	I-NP	O
,	,	,	O	O
shoulders/multiple	shoulders/multiple	JJ	B-NP	O
Hickman	Hickman	NNP	I-NP	O
associated	associate	VBN	I-NP	O
line	line	NN	I-NP	O
infections	infection	NNS	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
somnolence	somnolence	NN	B-NP	O
and	and	CC	O	O
total	total	JJ	B-NP	O
body	body	NN	I-NP	O
pain	pain	NN	I-NP	O
on	on	IN	B-PP	O
10/11	10/11	CD	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
provide	provide	VB	I-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
?	?	.	O	O
?	?	.	O	O
_____	_____	''	O	B-cell_line
?	?	.	O	O
?	?	.	O	O
moments	moment	NNS	B-NP	O
of	of	IN	B-PP	O
clarity	clarity	NN	B-NP	O
and	and	CC	O	O
would	would	MD	B-VP	O
say	say	VB	I-VP	O
pain	pain	VB	I-VP	O
all	all	DT	B-ADVP	O
over	over	IN	I-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
episodes	episode	NNS	B-NP	O
of	of	IN	B-PP	O
somnolence	somnolence	NN	B-NP	O
from	from	IN	B-PP	O
excessive	excessive	JJ	B-NP	O
pain	pain	NN	I-NP	O
medication	medication	NN	I-NP	O
use	use	NN	I-NP	O
?	?	.	O	O
?	?	.	O	O
______	______	''	O	B-cell_line
?	?	.	O	O
?	?	.	O	O
presentation	presentation	NN	B-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
bacteremic	bacteremic	JJ	B-ADJP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
previous	previous	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
on	on	IN	B-PP	O
3/21	3/21	CD	B-NP	O
.	.	.	O	O

According	Accord	VBG	B-PP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
daughter	daughter	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
one	one	CD	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
inability	inability	NN	B-NP	O
to	to	TO	B-VP	O
walk	walk	VB	I-VP	O
with	with	IN	B-PP	O
complaints	complaint	NNS	B-NP	O
of	of	IN	B-PP	O
pain	pain	NN	B-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
legs	leg	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
not	not	RB	I-VP	O
reported	report	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
any	any	DT	B-NP	O
symptoms	symptom	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
fevers	fever	NNS	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
her	her	PRP$	B-NP	O
pain	pain	NN	I-NP	O
became	become	VBD	B-VP	O
increasingly	increasingly	RB	B-ADJP	O
intense	intense	JJ	I-ADJP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
became	become	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
get	get	VB	I-VP	O
comfortable	comfortable	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Department	Department	NNP	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
vitals	vital	NNS	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
temperature	temperature	NN	I-NP	O
of	of	IN	B-PP	O
98.7	98.7	CD	B-NP	O
,	,	,	O	O
pressure	pressure	NN	B-NP	O
99/67	99/67	CD	I-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
106	106	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
20	20	CD	B-NP	O
,	,	,	O	O
sating	sate	VBG	B-VP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
deferoxamine	deferoxamine	NN	B-NP	O
,	,	,	O	O
vancomycin	vancomycin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
ceftazidine	ceftazidine	NN	B-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Notable	Notable	NNP	B-NP	O
for	for	IN	B-PP	O
aplastic	aplastic	JJ	B-NP	O
anemia	anemia	NN	I-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
thymoglobulin	thymoglobulin	NN	B-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
trial	trial	NN	I-NP	O
of	of	IN	B-PP	O
thymoglobulin	thymoglobulin	NN	B-NP	B-protein
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
reaction	reaction	NN	I-NP	O
and	and	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
tolerate	tolerate	VB	I-VP	O
it	it	PRP	B-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
cyclosporine	cyclosporine	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
HCV	HCV	NN	B-NP	B-protein
,	,	,	O	O
avascular	avascular	JJ	B-NP	O
necrosis	necrosis	NN	I-NP	O
,	,	,	O	O
polyarticular	polyarticular	JJ	B-NP	O
arthritis	arthritis	NN	I-NP	O
with	with	IN	B-PP	O
bilateral	bilateral	JJ	B-NP	O
hip	hip	NN	I-NP	O
replacement	replacement	NN	I-NP	O
and	and	CC	O	O
bilateral	bilateral	JJ	B-NP	O
shoulder	shoulder	NN	I-NP	O
replacement	replacement	NN	I-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
control	control	VB	I-VP	O
on	on	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
,	,	,	O	O
iron	iron	NN	B-NP	O
overload	overload	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
transfusions	transfusion	NNS	B-NP	O
,	,	,	O	O
hypothyroidism	hypothyroidism	NN	B-NP	O
,	,	,	O	O
amenorrhea	amenorrhea	NN	B-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
TAH	TAH	NN	I-NP	O
for	for	IN	B-PP	O
endometriosis/cervical	endometriosis/cervical	JJ	B-NP	O
carcinoma	carcinoma	NN	I-NP	O
,	,	,	O	O
osteomalacia	osteomalacia	NN	B-NP	O
and	and	CC	O	O
blind	blind	JJ	B-NP	O
right	right	JJ	I-NP	O
eye	eye	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
medication	medication	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
were	be	VBD	B-VP	O
Lantus	Lantus	NNP	B-NP	O
25	25	CD	I-NP	O
subq	subq	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
,	,	,	O	O
Novolog	Novolog	NNP	B-NP	O
12	12	CD	I-NP	O
units	unit	NNS	I-NP	O
subq	subq	NN	I-NP	O
a.c.	a.c.	NN	I-NP	O
,	,	,	O	O
Zoloft	Zoloft	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
lisinopril	lisinopril	VBP	B-VP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
,	,	,	O	O
Ambien	Ambien	NNP	B-NP	O
p.r.n.	p.r.n.	NNP	I-NP	O
,	,	,	O	O
hydrochlorothiazide	hydrochlorothiazide	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
,	,	,	O	O
quinine	quinine	NN	B-NP	O
sulfate	sulfate	NN	I-NP	O
260	260	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
,	,	,	O	O
thiamine	thiamine	NN	B-NP	O
,	,	,	O	O
folate	folate	NN	B-NP	O
,	,	,	O	O
oxycodone	oxycodone	NN	B-NP	O
90	90	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
,	,	,	O	O
methadone	methadone	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
Baclofen	Baclofen	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
t.i.d.	t.i.d.	FW	I-ADVP	O
,	,	,	O	O
Protonix	Protonix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Levoxyl	Levoxyl	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
vitamin	vitamin	NN	B-NP	O
D	D	NN	I-NP	O
,	,	,	O	O
calcium	calcium	NN	B-NP	O
carbonate	carbonate	NN	I-NP	O
,	,	,	O	O
Desferal	Desferal	JJ	B-NP	O
2	2	CD	I-NP	O
g	g	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
written	write	VBN	B-VP	O
as	as	IN	B-PP	O
no	no	DT	B-ADVP	O
longer	longer	RB	I-ADVP	O
necessary	necessary	JJ	B-ADJP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
allergies	allergy	NNS	I-NP	O
include	include	VBP	B-VP	O
NSAIDs	NSAID	NNS	B-NP	O
and	and	CC	O	O
aspirin	aspirin	NN	B-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
low	low	JJ	B-NP	B-cell_type
platelets	platelet	NNS	I-NP	I-cell_type
and	and	CC	O	O
acetaminophen	acetaminophen	NN	B-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
liver	liver	NN	B-NP	O
problems	problem	NNS	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Remarkable	Remarkable	JJ	B-ADJP	O
for	for	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
three	three	CD	B-NP	O
children	child	NNS	I-NP	O
.	.	.	O	O

Has	Has	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
tobacco	tobacco	NN	B-NP	O
one	one	CD	I-NP	O
pack	pack	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
for	for	IN	B-PP	O
20	20	CD	B-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
occasional	occasional	JJ	B-NP	O
alcohol	alcohol	NN	I-NP	O
and	and	CC	O	O
prior	prior	JJ	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
cocaine	cocaine	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
healthcare	healthcare	NN	I-NP	O
proxy	proxy	NN	I-NP	O
is	be	VBZ	B-VP	O
Laverne	Laverne	NNP	B-NP	O
Baxley	Baxley	NNP	I-NP	O
,	,	,	O	O
phone	phone	NN	B-NP	O
number	number	NN	I-NP	O
413-588-1750	413-588-1750	CD	B-NP	O
or	or	CC	O	O
cell	cell	NN	B-NP	O
phone	phone	NN	I-NP	O
340-975-4632	340-975-4632	CD	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
code	code	NN	I-NP	O
status	status	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
full	full	JJ	I-NP	O
code	code	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
physical	physical	JJ	I-NP	O
exam	exam	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
temperature	temperature	NN	I-NP	O
of	of	IN	B-PP	O
96.9	96.9	CD	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
109	109	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
136/92	136/92	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
16	16	CD	B-NP	O
,	,	,	O	O
sating	sate	VBG	B-VP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

Physical	Physical	JJ	B-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
difficulty	difficulty	NN	B-NP	O
with	with	IN	B-PP	O
following	follow	VBG	B-NP	O
commands	command	NNS	I-NP	O
.	.	.	O	O

Heart	Heart	NNP	B-NP	O
was	be	VBD	B-VP	O
regular	regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	O	O
rubs	rub	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
gallops	gallop	NNS	B-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
with	with	IN	B-PP	O
poor	poor	JJ	B-NP	O
respiratory	respiratory	JJ	I-NP	O
effort	effort	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
wheezes	wheeze	NNS	I-NP	O
or	or	CC	I-NP	O
crackles	crackle	NNS	I-NP	O
appreciated	appreciate	VBN	B-VP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
was	be	VBD	B-VP	O
soft	soft	JJ	B-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
hepatomegaly	hepatomegaly	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
and	and	CC	B-PP	O
on	on	IN	B-PP	O
neuro	neuro	NN	B-NP	O
exam	exam	NN	I-NP	O
,	,	,	O	O
required	require	VBD	B-VP	O
frequent	frequent	JJ	B-NP	O
refocusing	refocusing	NN	I-NP	O
to	to	TO	B-PP	O
main	main	JJ	B-NP	O
attention	attention	NN	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
count	count	VB	I-VP	O
backwards	backward	NNS	B-NP	O
from	from	IN	B-PP	O
10	10	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
initiate	initiate	VB	I-VP	O
any	any	DT	B-NP	O
spontaneous	spontaneous	JJ	I-NP	O
speech	speech	NN	I-NP	O
except	except	IN	B-PP	O
when	when	WRB	B-ADVP	O
distressed	distressed	JJ	B-ADJP	O
or	or	CC	O	O
in	in	IN	B-PP	O
pain	pain	NN	B-NP	O
.	.	.	O	O

LABS	LABS	NN	B-NP	B-protein
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
0.67	0.67	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
19.6	19.6	CD	I-NP	I-protein
and	and	CC	O	O
platelets	platelet	NNS	B-NP	B-cell_type
of	of	IN	B-PP	O
11	11	CD	B-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
differential	differential	JJ	I-NP	O
had	have	VBD	B-VP	O
53	53	CD	B-NP	O
%	%	NN	I-NP	O
polys	poly	NNS	I-NP	O
,	,	,	O	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
bands	band	NNS	I-NP	O
.	.	.	O	O

BUN	BUN	NN	B-NP	O
of	of	IN	B-PP	O
14	14	CD	B-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
of	of	IN	B-PP	O
2.2	2.2	CD	B-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
of	of	IN	B-PP	O
288	288	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
ALT	ALT	NN	I-NP	B-protein
was	be	VBD	B-VP	O
64	64	CD	B-NP	O
,	,	,	O	O
AST	AST	NN	B-NP	O
71	71	CD	I-NP	O
,	,	,	O	O
alk	alk	NN	B-NP	O
phos	pho	NNS	I-NP	O
107	107	CD	B-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
bili	bili	NNS	I-NP	O
0.7	0.7	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
UA	UA	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
LE	LE	NN	B-NP	O
positive	positive	JJ	B-ADJP	O
,	,	,	O	O
6-10	6-10	CD	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
2-5	2-5	CD	B-NP	O
red	red	JJ	I-NP	O
blood	blood	NN	I-NP	O
cells	cell	NNS	I-NP	O
and	and	CC	O	O
4	4	CD	B-NP	O
+	+	SYM	I-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

Urine	Urine	NN	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

ASSESSMENT	ASSESSMENT	NN	B-NP	O
:	:	:	O	O
A	A	DT	B-NP	O
41-year-old	41-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
,	,	,	O	O
long	long	RB	B-ADVP	O
standing	stand	VBG	B-VP	O
aplastic	aplastic	JJ	B-NP	O
anemia	anemia	NN	I-NP	O
transfusion	transfusion	NN	I-NP	O
dependent	dependent	JJ	B-ADJP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
avascular	avascular	JJ	B-NP	O
necrosis	necrosis	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
infections	infection	NNS	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
came	come	VBD	B-VP	O
in	in	RP	B-PRT	O
with	with	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
leg	leg	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Subsequently	Subsequently	RB	B-ADVP	O
found	find	VBN	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
urosepsis	urosepsis	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
Klebsiella	Klebsiella	NN	I-NP	O
bacteremia	bacteremia	NN	I-NP	O
with	with	IN	B-PP	O
course	course	NN	B-NP	O
complicated	complicate	VBN	B-VP	O
by	by	IN	B-PP	O
development	development	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
cholecystitis	cholecystitis	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
SYSTEM	SYSTEM	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
Blood	Blood	NN	B-NP	O
cultures	culture	NNS	I-NP	O
grew	grow	VBD	B-VP	O
Klebsiella	Klebsiella	NNP	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
urine	urine	NN	B-NP	O
culture	culture	NN	I-NP	O
grew	grow	VBD	B-VP	O
Klebsiella	Klebsiella	NNP	B-NP	O
,	,	,	O	O
determined	determine	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
urosepsis	urosepsis	NN	I-NP	O
During	During	IN	B-PP	O
her	her	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

Was	Be	VBD	B-VP	O
hypotensive	hypotensive	JJ	B-NP	O
requiring	require	VBG	I-NP	O
transport	transport	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
MICU	MICU	NNP	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
pressors	pressor	NNS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
ceftazidine	ceftazidine	NN	B-NP	O
that	that	WDT	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
?	?	.	O	O
?	?	.	O	O
_____	_____	''	O	B-cell_line
?	?	.	O	I-cell_line
?	?	.	O	I-cell_line
levofloxacin	levofloxacin	NN	B-NP	I-cell_line
when	when	WRB	B-ADVP	I-cell_line
her	her	PRP$	B-NP	I-cell_line
cultures	culture	NNS	I-NP	I-cell_line
came	come	VBD	B-VP	O
back	back	RB	B-ADJP	O
sensitive	sensitive	JJ	I-ADJP	O
.	.	.	O	O

Also	Also	RB	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
complicated	complicate	VBN	B-VP	O
by	by	IN	B-PP	O
development	development	NN	B-NP	O
of	of	IN	B-PP	O
cholecystitis	cholecystitis	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
amp	amp	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Flagyl	Flagyl	NN	B-NP	O
to	to	TO	B-VP	O
cover	cover	VB	I-VP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
cholecystitis	cholecystitis	NN	I-NP	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Levaquin	Levaquin	NNP	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
complete	complete	VB	I-VP	O
a	a	DT	B-NP	O
10-day	10-day	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
amp	amp	NN	B-NP	O
,	,	,	O	O
levo	levo	NN	B-NP	O
,	,	,	O	O
Flagyl	Flagyl	NN	B-NP	O
after	after	IN	B-PP	O
her	her	PRP$	B-NP	B-cell_line
last	last	JJ	I-NP	I-cell_line
positive	positive	JJ	I-NP	I-cell_line
culture	culture	NN	I-NP	I-cell_line
,	,	,	O	O
which	which	WDT	B-NP	O
would	would	MD	B-VP	O
take	take	VB	I-VP	O
her	her	PRP$	B-NP	O
up	up	RP	I-NP	O
until	until	IN	B-PP	O
9/12	9/12	CD	B-NP	O
to	to	TO	B-VP	O
discontinue	discontinue	VB	I-VP	O
the	the	DT	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
.	.	.	O	O

Prior	Prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
additional	additional	JJ	B-NP	O
blood	blood	NN	I-NP	O
culture	culture	NN	I-NP	O
was	be	VBD	B-VP	O
collected	collect	VBN	I-VP	O
to	to	TO	B-VP	O
ensure	ensure	VB	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
cleared	clear	VBN	I-VP	O
her	her	PRP$	B-NP	O
bacteremia	bacteremia	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
replacing	replace	VBG	B-VP	O
the	the	DT	B-NP	O
Hickman	Hickman	NNP	I-NP	B-cell_line
line	line	NN	I-NP	I-cell_line
.	.	.	O	O

This	This	DT	B-NP	O
blood	blood	NN	I-NP	O
culture	culture	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
up	up	RP	B-PRT	O
before	before	IN	B-PP	O
the	the	DT	B-NP	O
Hickman	Hickman	NNP	I-NP	O
line	line	NN	I-NP	O
is	be	VBZ	B-VP	O
placed	place	VBN	I-VP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Neuro	Neuro	NNP	B-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
had	have	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
pain	pain	NN	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Baseline	Baseline	NNP	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
chronic	chronic	JJ	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
high	high	JJ	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
oxycodone	oxycodone	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
methadone	methadone	NN	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
acute	acute	JJ	B-NP	O
full	full	JJ	I-NP	O
body	body	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
pain	pain	NN	I-NP	O
improved	improve	VBD	B-VP	O
as	as	IN	B-PP	O
her	her	PRP$	B-NP	O
infection	infection	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
and	and	CC	O	O
returned	return	VBN	B-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
level	level	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
daughter	daughter	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
frequently	frequently	RB	B-ADJP	O
somnolent	somnolent	JJ	I-ADJP	O
,	,	,	O	O
was	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
from	from	IN	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
as	as	IN	B-PP	O
her	her	PRP$	B-NP	O
sepsis	sepsis	NN	I-NP	O
resolved	resolve	VBD	B-VP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
somnolence	somnolence	NN	I-NP	O
improved	improve	VBD	B-VP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
.	.	.	O	O

During	During	IN	B-PP	O
hospital	hospital	NN	B-NP	O
course	course	NN	I-NP	O
had	have	VBD	B-VP	O
one	one	CD	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
dry	dry	JJ	B-NP	O
cough	cough	NN	I-NP	O
with	with	IN	B-PP	O
scant	scant	JJ	B-NP	O
hemoptysis	hemoptysis	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
low	low	JJ	B-NP	B-cell_type
platelets	platelet	NNS	I-NP	I-cell_type
.	.	.	O	O

Her	Her	PRP$	B-NP	O
cough	cough	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
persist	persist	VB	I-VP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
oxygen	oxygen	NN	I-NP	O
saturation	saturation	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
was	be	VBD	B-VP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Cardiovascularwise	Cardiovascularwise	RB	B-ADVP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
pump	pump	NN	I-NP	O
perspective	perspective	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
EF	EF	NN	I-NP	B-protein
was	be	VBD	B-VP	O
35	35	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
global	global	JJ	B-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
,	,	,	O	O
trace	trace	NN	B-NP	O
AI	AI	NN	I-NP	O
.	.	.	O	O

Initially	Initially	RB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
fluid	fluid	NN	B-NP	O
overloaded	overload	VBN	B-VP	O
following	follow	VBG	B-PP	O
resuscitation	resuscitation	NN	B-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
autodiuresed	autodiurese	VBN	B-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
hydrochlorothiazide	hydrochlorothiazide	NN	B-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
hypertension	hypertension	NN	I-NP	O
.	.	.	O	O

Rythmwise	Rythmwise	RB	B-ADVP	O
,	,	,	O	O
initially	initially	RB	B-ADVP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
sinus	sinus	NN	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
sepsis	sepsis	NN	I-NP	O
.	.	.	O	O

Then	Then	RB	B-ADVP	O
on	on	IN	B-PP	O
3/28	3/28	CD	B-NP	O
,	,	,	O	O
developed	develop	VBD	B-VP	O
atrial	atrial	JJ	B-NP	O
flutter	flutter	NN	I-NP	O
with	with	IN	B-PP	O
rates	rate	NNS	B-NP	O
up	up	RB	B-PP	O
to	to	TO	B-PP	O
150s	150	NNS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
IV	IV	CD	B-NP	O
Lopressor	Lopressor	NNP	I-NP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
converted	convert	VBD	B-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
sinus	sinus	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
p.o.	p.o.	FW	B-NP	O
metoprolol	metoprolol	NN	I-NP	O
for	for	IN	B-PP	O
rate	rate	NN	B-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
anticoagulated	anticoagulate	VBN	I-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	B-cell_type
low	low	JJ	I-NP	I-cell_type
platelets	platelet	NNS	I-NP	I-cell_type
and	and	CC	O	O
bleeding	bleed	VBG	B-VP	O
risk	risk	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Vascular	Vascular	JJ	B-ADJP	O
:	:	:	O	O
It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
swollen	swell	VBN	I-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
tender	tender	NN	B-NP	O
,	,	,	O	O
right	right	RB	B-ADVP	O
greater	great	JJR	I-ADVP	O
than	than	IN	B-PP	O
left	left	JJ	B-ADJP	O
,	,	,	O	O
after	after	IN	B-SBAR	O
transfer	transfer	NN	B-NP	O
out	out	RB	B-ADVP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
MICU	MICU	NN	I-NP	B-DNA
.	.	.	O	O

Pulses	Pulse	NNS	B-NP	O
were	be	VBD	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
move	move	VB	I-VP	O
her	her	PRP$	B-NP	O
feet	foot	NNS	I-NP	O
.	.	.	O	O

?	?	.	O	O
?	?	.	O	O
_____	_____	''	O	B-cell_line
?	?	.	O	O
?	?	.	O	O
were	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
and	and	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
show	show	VB	I-VP	O
any	any	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
DVT	DVT	NN	B-NP	B-protein
.	.	.	O	O

Her	Her	PRP$	B-NP	O
swelling	swelling	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
decrease	decrease	VB	I-VP	O
as	as	IN	B-SBAR	O
she	she	PRP	B-NP	O
diuresed	diurese	VBD	B-VP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
During	During	IN	B-PP	O
her	her	PRP$	B-NP	O
MICU	MICU	NN	I-NP	O
stay	stay	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
developed	develop	VBD	B-VP	O
right	right	JJ	B-NP	O
upper	upper	JJ	I-NP	O
quadrant	quadrant	JJ	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
suggestive	suggestive	JJ	B-ADJP	O
of	of	IN	B-PP	O
cholecystitis	cholecystitis	NN	B-NP	O
.	.	.	O	O

Surgery	Surgery	NN	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
high	high	JJ	I-NP	O
surgical	surgical	JJ	I-NP	O
risk	risk	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
decided	decide	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
managed	manage	VBN	I-VP	O
medically	medically	RB	B-ADVP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
bilirubin	bilirubin	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
trend	trend	VB	I-VP	O
down	down	RP	B-PRT	O
.	.	.	O	O

She	She	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
tolerate	tolerate	VB	I-VP	O
p.o.	p.o.	NN	B-NP	O
liquids	liquid	NNS	I-NP	O
and	and	CC	O	O
food	food	NN	B-NP	O
and	and	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
complain	complain	VB	I-VP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
quadrant	quadrant	JJ	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-VP	O
her	her	PRP$	B-NP	O
chronic	chronic	JJ	I-NP	O
esophagitis	esophagitis	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
epigastric	epigastric	JJ	B-NP	O
discomfort	discomfort	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
kept	keep	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
PPI	PPI	NN	I-NP	B-protein
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
may	may	MD	B-VP	O
also	also	RB	I-VP	O
continue	continue	VB	I-VP	O
Carafate	Carafate	NNP	B-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hepatitis	hepatitis	NN	B-NP	O
C	C	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
with	with	IN	B-PP	O
Liver	Liver	NNP	B-NP	O
Clinic	Clinic	NNP	I-NP	O
following	follow	VBG	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
aplastic	aplastic	JJ	B-NP	O
anemia	anemia	NN	I-NP	O
of	of	IN	B-PP	O
unknown	unknown	JJ	B-NP	O
etiology	etiology	NN	I-NP	O
since	since	IN	B-PP	O
age	age	NN	B-NP	O
12	12	CD	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
goal	goal	NN	I-NP	O
of	of	IN	B-PP	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
23	23	CD	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
platelets	platelet	NNS	I-NP	B-cell_type
fluctuated	fluctuate	VBD	B-VP	O
as	as	RB	B-ADVP	O
low	low	JJ	I-ADVP	O
as	as	IN	B-PP	O
3	3	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
receive	receive	VB	I-VP	O
two	two	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
HLA	HLA	NN	B-NP	B-cell_type
matched	matched	JJ	I-NP	I-cell_type
platelets	platelet	NNS	I-NP	I-cell_type
,	,	,	O	O
which	which	WDT	B-NP	O
increased	increase	VBD	B-VP	O
her	her	PRP$	B-NP	O
platelets	platelet	NNS	I-NP	B-cell_type
to	to	TO	B-PP	O
19	19	CD	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
known	know	VBN	I-VP	O
to	to	TO	I-VP	O
tolerate	tolerate	VB	I-VP	O
platelets	platelet	NNS	B-NP	B-cell_type
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
5	5	CD	I-NP	O
and	and	CC	O	O
unless	unless	IN	B-SBAR	O
a	a	DT	B-NP	O
concern	concern	NN	I-NP	O
for	for	IN	B-PP	O
bleeding	bleed	VBG	B-VP	O
,	,	,	O	O
I	I	PRP	B-NP	O
would	would	MD	B-VP	O
not	not	RB	I-VP	O
further	further	VB	I-VP	O
transfuse	transfuse	NN	B-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
at	at	IN	B-PP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
of	of	IN	B-PP	O
1.5	1.5	CD	B-NP	O
.	.	.	O	O

Electrolytes	Electrolyte	NNS	B-NP	O
were	be	VBD	B-VP	O
fallena	fallena	NN	B-NP	O
and	and	CC	O	O
repleted	replete	VBN	B-VP	O
as	as	RB	B-ADJP	O
necessary	necessary	JJ	I-ADJP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Endocrine	Endocrine	JJ	B-ADJP	O
:	:	:	O	O
Diabetes	Diabete	NNS	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
sugar	sugar	NN	I-NP	O
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-PP	O
control	control	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
kept	keep	VBN	I-VP	O
on	on	IN	B-PP	O
Lantus	Lantus	NNP	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Novolog	Novolog	NNP	B-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
insulin	insulin	NN	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

PROPHYLAXIS	PROPHYLAXIS	NNS	B-NP	O
:	:	:	O	O
Pneumaboots	Pneumaboot	NNS	B-NP	O
given	give	VBN	B-VP	O
her	her	PRP$	B-NP	O
low	low	JJ	I-NP	B-cell_type
platelets	platelet	NNS	I-NP	I-cell_type
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
PPI	PPI	NN	I-NP	B-protein
.	.	.	O	O

TUBES	TUBES	NNS	B-NP	O
,	,	,	O	O
LINES	LINES	NNP	B-NP	O
AND	AND	CC	I-NP	O
DRAINS	DRAINS	NNP	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
3	3	CD	I-NP	O
port	port	NN	I-NP	O
right	right	JJ	I-NP	O
IJ	IJ	NN	I-NP	O
catheter	catheter	NN	I-NP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
and	and	CC	O	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
with	with	IN	B-PP	O
until	until	IN	B-PP	O
her	her	PRP$	B-NP	O
Hickman	Hickman	NNP	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
placed	place	VBN	I-VP	O
.	.	.	O	O

Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
scheduled	schedule	VBN	I-VP	O
for	for	IN	B-SBAR	O
her	her	PRP	B-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
IR	IR	NN	B-NP	O
place	place	NN	I-NP	O
another	another	DT	B-NP	O
Hickman	Hickman	NNP	I-NP	O
.	.	.	O	O

Prior	Prior	RB	B-ADVP	O
to	to	TO	B-PP	O
placement	placement	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
should	should	MD	B-VP	O
have	have	VB	I-VP	O
her	her	PRP$	B-NP	O
final	final	JJ	I-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
evaluated	evaluate	VBN	B-VP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
AT	AT	IN	B-PP	O
THE	THE	DT	B-NP	O
TIME	TIME	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
:	:	:	O	O
Include	Include	NNP	B-NP	O
Dulcolax	Dulcolax	NNP	I-NP	O
10-20	10-20	CD	I-NP	O
mg	mg	NN	I-NP	O
?	?	.	O	O
?	?	.	O	O
_____	_____	''	O	B-cell_line
?	?	.	O	O
?	?	.	O	O
p.r.n.	p.r.n.	JJ	B-NP	O
constipation	constipation	NN	I-NP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
hydrochlorothiazide	hydrochlorothiazide	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Levoxyl	Levoxyl	NN	B-NP	O
75	75	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
methadone	methadone	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
oxycodone	oxycodone	NN	B-NP	O
30-60	30-60	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q	q	NN	I-NP	O
4h	4h	NN	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
,	,	,	O	O
Zoloft	Zoloft	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
levofloxacin	levofloxacin	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.	q.	FW	I-NP	O
48h	48h	NN	I-NP	O
,	,	,	O	O
to	to	TO	B-VP	O
receive	receive	VB	I-VP	O
final	final	JJ	B-NP	O
dose	dose	NN	I-NP	O
on	on	IN	B-PP	O
3/22/05	3/22/05	CD	B-NP	O
,	,	,	O	O
Protonix	Protonix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Lantus	Lantus	NNP	B-NP	O
25	25	CD	I-NP	O
units	unit	NNS	I-NP	O
subq	subq	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
,	,	,	O	O
Novolog	Novolog	NNP	B-NP	O
12	12	CD	I-NP	O
units	unit	NNS	I-NP	O
subq	subq	NN	I-NP	O
a.c.	a.c.	NN	I-NP	O
,	,	,	O	O
ampicillin	ampicillin	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.	q.	FW	I-NP	O
6h	6h	NN	I-NP	O
,	,	,	O	O
to	to	TO	B-VP	O
complete	complete	VB	I-VP	O
final	final	JJ	B-NP	O
dose	dose	NN	I-NP	O
on	on	IN	B-PP	O
3/22/05	3/22/05	CD	B-NP	O
,	,	,	O	O
Toprol	Toprol	NNP	B-NP	O
XL	XL	NNP	I-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
thiamine	thiamine	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
folate	folate	VB	B-VP	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Baclofen	Baclofen	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
calcium	calcium	NN	B-NP	O
carbonate	carbonate	NN	I-NP	O
1250	1250	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
Flagyl	Flagyl	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
t.i.d.	t.i.d.	FW	I-ADVP	O
,	,	,	O	O
to	to	TO	B-VP	O
complete	complete	VB	I-VP	O
last	last	JJ	B-NP	O
dose	dose	NN	I-NP	O
on	on	IN	B-PP	O
3/22/05	3/22/05	CD	B-NP	O
and	and	CC	O	O
vitamin	vitamin	NN	B-NP	O
D	D	NN	I-NP	O
50	50	CD	B-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
units	unit	NNS	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Interventional	Interventional	NNP	B-NP	O
Radiology	Radiology	NNP	I-NP	O
,	,	,	O	O
telephone	telephone	NN	B-NP	O
number	number	NN	I-NP	O
302-193-2353	302-193-2353	CD	I-NP	O
for	for	IN	B-PP	O
placement	placement	NN	B-NP	O
of	of	IN	B-PP	O
Hickman	Hickman	NNP	B-NP	O
line	line	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
scheduled	schedule	VBN	I-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Liver	Liver	NNP	B-NP	O
Clinic	Clinic	NNP	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Marsella	Marsella	NNP	I-NP	O
on	on	IN	B-PP	O
1/13/05	1/13/05	CD	B-NP	O
at	at	IN	B-PP	O
4	4	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
p.m.	p.m.	RB	I-NP	O
and	and	CC	O	O
finally	finally	RB	B-ADVP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Ellis	Ellis	NNP	I-NP	O
Canori	Canori	NNP	I-NP	O
her	her	PRP$	B-NP	O
hematologist	hematologist	NN	I-NP	O
regarding	regard	VBG	B-VP	O
future	future	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
aplastic	aplastic	JJ	I-NP	O
anemia	anemia	NN	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
any	any	DT	B-NP	O
questions	question	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
meantime	meantime	NN	I-NP	O
or	or	CC	O	O
Dr.	Dr.	NNP	B-NP	O
Thomases	Thomases	NNP	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
available	available	JJ	B-ADJP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Cartrette	Cartrette	NNP	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
contacted	contact	VBN	I-VP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
1-7417000	1-7417000	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Angel	Angel	NNP	B-NP	O
Ketchen	Ketchen	NNP	I-NP	O
MD	MD	NNP	I-NP	O
Cinponce	Cinponce	NNP	I-NP	O
Ster	Ster	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Jackson	Jackson	NNP	B-NP	O
Paglione	Paglione	NNP	I-NP	O
MD	MD	NNP	I-NP	O
Ok	Ok	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
DIETZLER	DIETZLER	NN	B-NP	O
,	,	,	O	O
GUSTAVO	GUSTAVO	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
KASSEM	KASSEM	NN	B-NP	O
,	,	,	O	O
ANDREW	ANDREW	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
7190278	7190278	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
4/18/05	4/18/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
4/18/05	4/18/05	CD	B-NP	O

